Clinical Trial Update: Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immunonutrition and quality of life in gastrointestinal cancer patients undergoing oncological treatment; the study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Immunonutrition product (immunonutrition supplement)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Gastrointestinal Cancer | Phase 3 | Status: COMPLETED